{
    "title": "Pfizer's COVID cash pile opens opportunities for deals",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10486211/Pfizers-COVID-cash-pile-opens-opportunities-deals.html",
    "date": "2022-02-07",
    "keywords": [
        "pfizer",
        "paxlovid",
        "cash",
        "vaccine",
        "year",
        "index",
        "dividend",
        "covid19",
        "drugmaker",
        "revenue",
        "production",
        "profit",
        "drug",
        "divan",
        "pipeline",
        "time",
        "mampa",
        "loncar",
        "yield",
        "hope",
        "onceinageneration",
        "infusion",
        "figure",
        "executive",
        "albert",
        "bourla",
        "treatment",
        "biontech",
        "se",
        "percent",
        "canada",
        "uk",
        "europe",
        "average",
        "purchase",
        "contract",
        "sixth",
        "analyst",
        "vamil",
        "patent",
        "protection",
        "growth",
        "surge",
        "biotechnology",
        "biotech",
        "sector",
        "driver",
        "investor",
        "brad",
        "cancer",
        "developer",
        "trillium",
        "flood",
        "money",
        "component",
        "deployment",
        "event",
        "dow",
        "gain",
        "sampp",
        "period",
        "range",
        "bengaluru",
        "michael",
        "erman",
        "jersey",
        "editing",
        "humer",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}